The Role of Imaging in Hypertensive Heart Disease

Abstract

Hypertensive heart disease (HHD) describes a spectrum of target organ response that includes left ventricular hypertrophy, systolic, and diastolic dysfunction. A variety of imaging techniques can be used to assess the various aspects of HHD. Echocardiography has for many years been the main imaging technique in the evaluation of HHD, but there is an increasing role for cardiovascular magnetic resonance (CMR) imaging due to its ability to provide an unrestricted field of view and noninvasive tissue characterization. This article reviews the current role of imaging for HHD with particular focus on echocardiography and CMR applications.

Keywords

echocardiography - magnetic resonance imaging - hypertension

• References

• 1 Drazner MH. The progression of hypertensive heart disease. Circulation 2011; 123 (3) 327-334
• 2 Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322 (22) 1561-1566
• 3 Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117 (3) 568-575
• 4 Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55 (4) 613-618
• 5 Alfakih K, Walters K, Jones T, Ridgway J, Hall AS, Sivananthan M. New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Hypertension 2004; 44 (2) 175-179
• 6 Devereux RB, Wachtell K, Gerdts E , et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004; 292 (19) 2350-2356
• 7 Ganau A, Devereux RB, Roman MJ , et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19 (7) 1550-1558
• 8 Ross Jr J. On variations in the cardiac hypertrophic response to pressure overload. Circulation 1997; 95 (6) 1349-1351
• 9 Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med 1969; 71 (1) 89-105
• 10 Pewsner D, Jüni P, Egger M, Battaglia M, Sundström J, Bachmann LM. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ 2007; 335 (7622): 711
• 11 Salcedo EE, Gockowski K, Tarazi RC. Left ventricular mass and wall thickness in hypertension. Comparison of M mode and two dimensional echocardiography in two experimental models. Am J Cardiol 1979; 44 (5) 936-940
• 12 Devereux RB, Alonso DR, Lutas EM , et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57 (6) 450-458
• 13 Li L, Shigematsu Y, Hamada M, Hiwada K. Relative wall thickness is an independent predictor of left ventricular systolic and diastolic dysfunctions in essential hypertension. Hypertens Res 2001; 24 (5) 493-499
• 14 Kühl HP, Schreckenberg M, Rulands D , et al. High-resolution transthoracic real-time three-dimensional echocardiography: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004; 43 (11) 2083-2090
• 15 Grothues F, Smith GC, Moon JC , et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002; 90 (1) 29-34
• 16 Rudolph A, Abdel-Aty H, Bohl S , et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 2009; 53 (3) 284-291
• 17 Ho CY, López B, Coelho-Filho OR , et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 2010; 363 (6) 552-563
• 18 Moon JC, Sachdev B, Elkington AG , et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003; 24 (23) 2151-2155
• 19 Smedema JP, Snoep G, van Kroonenburgh MP , et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45 (10) 1683-1690
• 20 Falk RH, Dubrey SW. Amyloid heart disease. Prog Cardiovasc Dis 2010; 52 (4) 347-361
• 21 Maceira AM, Joshi J, Prasad SK , et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005; 111 (2) 186-193
• 22 Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 2008; 10: 54-65
• 23 Petersen SE, Selvanayagam JB, Francis JM , et al. Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2005; 7 (3) 551-558
• 24 Shimizu G, Hirota Y, Kita Y, Kawamura K, Saito T, Gaasch WH. Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy. Circulation 1991; 83 (5) 1676-1684
• 25 Rosen BD, Saad MF, Shea S , et al. Hypertension and smoking are associated with reduced regional left ventricular function in asymptomatic: individuals the Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol 2006; 47 (6) 1150-1158
• 26 Redfield MM, Jacobsen SJ, Burnett Jr JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289 (2) 194-202
• 27 Smith VE, White WB, Meeran MK, Karimeddini MK. Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. J Am Coll Cardiol 1986; 8 (6) 1449-1454
• 28 Mattioli AV, Bonatti S, Monopoli D, Zennaro M, Mattioli G. Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension. Blood Press 2005; 14 (5) 273-278
• 29 Tsang TS, Abhayaratna WP, Barnes ME , et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter?. J Am Coll Cardiol 2006; 47 (5) 1018-1023
• 30 Ishida Y, Meisner JS, Tsujioka K , et al. Left ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure. Circulation 1986; 74 (1) 187-196
• 31 Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30 (6) 1527-1533
• 32 Narayanan A, Aurigemma GP, Chinali M, Hill JC, Meyer TE, Tighe DA. Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study. Circ Cardiovasc Imaging 2009; 2 (5) 382-390
• 33 Chai P, Mohiaddin R. How we perform cardiovascular magnetic resonance flow assessment using phase-contrast velocity mapping. J Cardiovasc Magn Reson 2005; 7 (4) 705-716
• 34 Moreo A, Ambrosio G, De Chiara B , et al. Influence of myocardial fibrosis on left ventricular diastolic function: non-invasive assessment by CMR and echo. Circ Cardiovasc Imaging 2009; 2 (6) 437-443
• 35 Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, de Leeuw PW, van Engelshoven JM. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001; 135 (6) 401-411
• 36 Hom JJ, Ordovas K, Reddy GP. Velocity-encoded cine MR imaging in aortic coarctation: functional assessment of hemodynamic events. Radiographics 2008; 28 (2) 407-416
• 37 Blake MA, Kalra MK, Maher MM , et al. Pheochromocytoma: an imaging chameleon. Radiographics 2004; 24 (Suppl. 01) S87-S99